Alector Inc logo

Alector Inc

1
NAS:ALEC (USA)  
$ 4.96 -0.13 (-2.55%) 03:00 PM EST
At Loss
P/B:
3.14
Market Cap:
$ 474.92M
Enterprise V:
$ -24.49M
Volume:
221.10K
Avg Vol (2M):
678.13K
Also Trade In:
Volume:
221.10K
At Loss
Avg Vol (2M):
678.13K

Business Description

Description
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.